Ebc Pharmaceuticals Private Limited
About Ebc Pharmaceuticals Private Limited
Data last updated:
Ebc Pharmaceuticals Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24290KL2020PTC061105. Its GSTIN is 32AAFCE7858Q1ZX (Kerala).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Kalarikkal Deepak Kumar (Managing Director) and Pranop Kumar Cheriyambalathil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thrissur, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.12 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹58,099 (net margin 0.3%) and EBITDA of ₹6.35 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoom No. 17/322 (51/1759) Netaji Road, Opp. Netaji Ground Aranattukara, Thrissur, Kerala, India – 680618
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ebc Pharmaceuticals Private Limited
The main business activity of Ebc Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ebc Pharmaceuticals Private Limited FY 2025 filings available
Ebc Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr (up 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ebc Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 50% growth in the latest year. EBITDA rose 209% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ebc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹58,099 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ebc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ebc Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Donewell Pharmaceuticals Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Rangia, Assam, India |
| Ajmera Pharmaceuticals Pvt Ltd | ₹2.15 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Indore, Madhya Pradesh, India |
| Granvalor Pharmaceuticals Private Limited | ₹2.14 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Tirupatimsshree Pharmaceuticals Private Limited | ₹2.13 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Noida, Uttar Pradesh, India |
| Humanize Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Pimpri, Maharashtra, India |
| Ebc Pharmaceuticals Private Limited this company | ₹2.12 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Thrissur, Kerala, India |
| Umapati Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | •••• | Muzaffrabad, Uttar Pradesh, India | |
| Dzire Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2025) | •••• | •••• | 94.0% | •••• | Hisar, Haryana, India |
| Bioquest Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Genin Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2018) | •••• | •••• | 364.0% | •••• | New Delhii, Delhi, India |
| Arizzer Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ebc Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranop Kumar Cheriyambalathil | Director | 11 Aug 2020 | 6 Years 2 Months | Current |
| Kalarikkal Deepak Kumar | Managing Director | 10 Jan 2020 | 6 Years 9 Months | Current |
| Raja Gopala Menon Also directs: Beskyn Science Private Limited, Ylabs Scientific Private Limited | Director | 24 Mar 2023 | 3 Years 6 Months | Current |
| Rejeesh Ramesan Remesh | Director | 23 Mar 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of Ebc Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ebc Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ebc Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals Private Limited has 10 board changes on record since 2020: 4 appointments and 6 cessations. The latest: Nadancheri Padikkal Padath Ajith ceased to be Director on 13 Jun 2023.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ebc Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ebc Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ebc Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCE7858Q1ZX | Kerala | Active | 01 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ebc Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ebc Pharmaceuticals Private Limited
Ebc Pharmaceuticals is an active private limited company based in Thrissur, Kerala, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 January 2020 (6+ years old) and is registered under CIN U24290KL2020PTC061105.
Ebc Pharmaceuticals reported revenue of ₹2.12 Cr for FY 2025 (up 50% YoY).
Ebc Pharmaceuticals has 4 current directors:
- Kalarikkal Deepak Kumar - Managing Director
- Pranop Kumar Cheriyambalathil - Director
- Raja Gopala Menon - Director
- Rejeesh Ramesan Remesh - Director
Ebc Pharmaceuticals reported a net profit of ₹58,099 (net margin 0.3%) and EBITDA of ₹6.35 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ebc Pharmaceuticals is 45% over three years. In the latest year (FY 2025) revenue rose 50%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ebc Pharmaceuticals is 32AAFCE7858Q1ZX, registered in Kerala.
The CIN (Corporate Identification Number) of Ebc Pharmaceuticals is U24290KL2020PTC061105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ebc Pharmaceuticals was incorporated on 10 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Ebc Pharmaceuticals by revenue are Donewell Pharmaceuticals Private Limited, Ajmera Pharmaceuticals Pvt Ltd, Granvalor Pharmaceuticals Private Limited, Tirupatimsshree Pharmaceuticals Private Limited, Humanize Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Nadancheri Padikkal Padath Ajith ceased to be Director on 13 Jun 2023. Pallipuram Village Narayanan Sahasranaman ceased to be Director on 13 Jun 2023. Panadan Poulose Shaju ceased to be Director on 13 Jun 2023. Ebc Pharmaceuticals has 10 board changes on record in total.
The registered office of Ebc Pharmaceuticals is at Room No. 17322 511759 Netaji Road, Opp. Netaji Ground Aranattukara, Thrissur, Kerala, India – 680618.